Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures

John P A Ioannidis

doi:10.1111/eci.13223

Related publications

Article2020

Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures

John P A Ioannidis

Article2023

Hypertension clinical care in the era of coronavirus disease 2019

Mangesh Tiwaskar, Prabhakar Koregol, Hari Krishnan, Dinesh Agarwal, Omer S. M. Hasan, Mahesh Abhyankar, Santosh Revankar, Neeraj Kumar

Article2023

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison

Nicolas Penel, Coralie Cantarel, Claire Chemin-Airiau, Françoise Ducimetière, F. Gouin, François Le Loarer, Maud Toulmonde, Sophie Piperno‐Neumann, Carine Bellera, Charles Honoré, Jean Yves Blay, Simone Mathoulin‐Pélissier

Article2022

Prognosis of Spontaneous Pneumothorax/Pneumomediastinum in Coronavirus Disease 2019: The CoBiF Score

Wongi Woo, Vincent Kipkorir, Adina Maria Marza, Shadi Hamouri, Omar Albawaih, Arkadeep Dhali, Woo-Shik Kim, Zarir Udwadia, Abdulqadir J. Nashwan, Nissar Shaikh, Alessandro Belletti, Giovanni Landoni, Diego Palumbo, Sarya Swed, Bisher Sawaf, Danilo Buonsenso, Inês Pimenta, Filipe Gonzalez, Giuseppe Fiorentino, Muhammad Redzwan S. Rashid Ali, Alvaro Quincho-Lopez, Mohammad Javanbakht, Ayat Alhakeem, Muhammad Mohsin Khan,

Article2020

Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?

Ralf Weiskirchen